Form 8-K - Current report:
SEC Accession No. 0001558370-25-003922
Filing Date
2025-03-28
Accepted
2025-03-28 08:47:40
Documents
15
Period of Report
2025-03-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpth-20250328x8k.htm   iXBRL 8-K 40959
2 EX-99.1 bpth-20250328xex99d1.htm EX-99.1 25884
3 GRAPHIC bpth-20250328xex99d1001.jpg GRAPHIC 10795
  Complete submission text file 0001558370-25-003922.txt   204927

Data Files

Seq Description Document Type Size
4 EX-101.SCH bpth-20250328.xsd EX-101.SCH 3288
5 EX-101.LAB bpth-20250328_lab.xml EX-101.LAB 15299
6 EX-101.PRE bpth-20250328_pre.xml EX-101.PRE 9743
17 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20250328x8k_htm.xml XML 4690
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS, INC. (Filer) CIK: 0001133818 (see all company filings)

EIN.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36333 | Film No.: 25781720
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)